by Lina | Feb 4, 2021 | Industry Insights
Increasingly, pharma is striving towards true patient centricity and here we explore how patient-focused drug development (PFDD) could have a direct impact on drug safety and adverse event management. The FDA is developing guidance for PFDD with the goal to better...
by Lina | Dec 21, 2020 | Industry Insights
For those of you who may be concerned or hesitant about receiving the COVID-19 vaccine, here’s what has helped our decision-making at Sprout. The only vaccinations to be approved for COVID-19 at the time of writing use the mRNA (messenger ribonucleic acid) method. We...
by Lina | Dec 21, 2020 | Industry Insights
We believe that successful roll-out of the COVID-19 vaccination will have a bigger impact on most people’s lives than anything else in 2021. Good uptake of the COVID-19 vaccine will be important for bringing the pandemic under control and allowing some normality to...
by Lina | Nov 30, 2020 | Industry Insights
Behavior Science Specialists Restructure Portfolio of Solutions-Based Offerings for Improved Health and Regulatory Success November 30 – London – Sprout Health Solutions, a UK-based global consultancy formerly known as Sprout Behaviour Change, announced their new name...
by Lina | Oct 5, 2020 | Medication Adherence
The challenge: To improve estimations of treatment adherence based on proportion of days covered (PDC) in real-world drug-dispensing dataset where all possible medication distribution points cannot be controlled. The study was conceived and funded by one of the UK’s...
